20/20 GeneSystems Wins $3M in SBIR Grants

The firm is using the grants to develop tests to help oncologists predict the effectiveness of targeted cancer therapies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories